Aug 21, 2025 - Our work highlighted by Stanford University’s Knight Initiative for Brain Resilience
Parkinson’s comes in many forms. New biomarkers may explain why. Blood and cerebrospinal fluid markers tied to inflammation and metabolism sort some patients into subgroups, according to Knight Initiative researchers, a step toward predicting progression and tailoring care. Read more about our work featured in Stanford's Knight Initiative